NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: ZOTA · data 2026-10-30

Zota Health Care Ltd.

₹1,328.8+0.39% on 30 OctHealth: Weak 3.3/10
Feb 2026Low ₹1,028.1 · High ₹1,444.9+3.4%

In plain words

Price: 23.6% below its 52-week high of ₹1,740.

Delivery: 59.3% of traded shares were kept for delivery over the last 10 sessions, against 57.3% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹1,328.8
Market cap
₹4,015 cr
P/E
—
P/B
7.4
ROE
-16.1%
ROCE
-9.7%
Debt / equity
0.39
Dividend yield
0.08%
1-year return
-15.4%
52-week high
₹1,740
52-week low
₹1,022
Operating margin
-15.6%

Growth

Revenue (last 12 months)₹679 cr
Net profit (last 12 months)₹-113 cr
Sales growth, 3 years (yearly)56.9%
Profit growth, 3 years (yearly)—

Smart-money activity

16/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-09-21: Dividend ₹1 (ex-date)

● Dividend

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Zota Health Care Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.39.

What is the 52-week high and low of Zota Health Care Ltd.?

The 52-week high is ₹1,740 and the 52-week low is ₹1,022.

Similar companies

Evonile Pharma Limited (NOVARTIND) · Gufic Biosciences Limited (GUFICBIO) · Aarti Drugs Limited (AARTIDRUGS) · Kwality Pharmaceuticals Ltd (KPL) · Ind-Swift Laboratories Ltd. (INDSWFTLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ZOTA in NSE Scanner →
Share on WhatsAppShare on Telegram